Elevated menopause proteomic scores are associated with poorer cognitive outcomes and increased risk for Alzheimer disease and dementia.

Semaglutide provides multifaceted kidney protection and improves structural markers in patients with T2D and chronic kidney disease.

Dual-hormone fully closed-loop therapy increases time in glycemic range compared with multiple daily insulin injections (MDI), but not compared with hybrid closed-loop (HCL) therapy in adults with ...

Sustained smoking cessation for at least 8 years significantly reduces risk for microvascular complications in patients with type 2 diabetes.

GLP-1 RAs and SGLT-2 inhibitors reduce risk for renal deterioration in patients with type 2 diabetes (T2D) and albuminuria.

Study reveals that fruit- and vegetable-rich diets are linked to fewer hospitalizations and slower progression to kidney failure. HealthDay News — For patients with stage 3 chronic kidney disease (CKD ...

Real-world data show mortality, kidney, and cardiovascular benefits even among those with frailty and multimorbidity. HealthDay News — Sodium-glucose cotransporter 2 (SGLT2) inhibitors show ...

Insulin resistance may partially explain the increased long-term cardiovascular risk. HealthDay News — Premature menopause is associated with higher insulin levels and a greater risk for ...

Postoperative benefits include lower odds of major adverse cardiovascular events or infections. HealthDay News — Perioperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated ...

Improvement were seen in the lumbar spine vs estrogen therapy alone in postmenopausal women. HealthDay News — The combination of estrogen and testosterone therapy (E+T) may improve bone mineral ...